cardin report mix quarter posit long-term
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim oct
price data
rate updat
currenc amount express
methodolog valu compani
cardin report mix quarter revenu grew
robust clip profit continu pressur
environ believ need sourc deliv
drug cost effect effici manner remain
posit fundament drug distributor dynam
form strong foundat cardin
competit posit view core drug
wholes oper need drug
manufactur retail pharmaci matter
market dynam shift accordingli reiter
wide-moat rate fair valu estim
cardin manag reiter guidanc year
confid expect incorpor conserv
outlook find encourag develop
point continu stabil oper gener
deflat moder brand inflat remain
expect trajectori manag state guidanc
incorpor scenario brand inflat could fall
basi point current expect
howev team state feel highli confid
inflat expect given convers
firm also reorgan oper manag
state everyth tabl part
reorgan includ firm refocus much
manageri bandwidth asset
build effici stabil core
pharmaceut wholesal segment major chang
firm previou strategi expand busi
portfolio global reach applaud new
manag team strategi model
modest profit improv segment forecast
oper margin expand basi point
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
cardin health major distributor pharmaceut medic
suppli pharmaci hospit also major logist partner
mani brand manufactur provid market forecast product
product inventori effici distribut servic player
largest retail pharmaci custom retail pharmaci
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
end explicit forecast period believ
reflect conserv outlook incorpor greater
infrastructur effici modest price spread less
variabl tie brand price
ceo mike kaufman state earn call
process revamp firm busi refocus
effort process improv continu well
fiscal year believ strategi posit
long-term given greater focu optim drug
wholes oper expand
specialti
pharmaceut oper perspect
effort ultim build signific sharehold valu
beyond fiscal cardin posit critic cogs
within global pharmaceut suppli chain
dynam provid opportun produc signific
econom profit long-term thu current
discount firm stock price present opportun
investor long-term time horizon wide moat
busi signific discount
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end june
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end june
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end june
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
